Xiaobing Dou

机构：Zhejiang Chinese Medical University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Zhejiang Medicine (China), Zhejiang University · ORCID：0000-0002-2465-3079

发表论文 109 篇 · 总被引 2416 次 · h-index 26

代表论文

• Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota (2025 · Food Research International · 被引 14)
• Role of mitochondrial Ca 2+ in stroke: From molecular mechanism to treatment strategy (Review) (2025 · Molecular Medicine Reports · 被引 11)
• Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα (2025 · Frontiers in Pharmacology · 被引 10)
• Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders (2025 · Phytomedicine · 被引 9)
• Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease (2025 · Science Advances · 被引 8)
• Bifidobacterium bifidum reduces oxidative stress and alters gut flora to mitigate acute liver injury caused by N-acetyl-p-aminophenol (2025 · BMC Microbiology · 被引 7)